18.04.2011 • NewsAzoty TarnowAzoty Tarnow fertilizerCiech

PGNiG to Get $54 Million for Tarnow Stake

Investors have bid 37 zlotys per share for Polish gas monopoly PGNiG's 10% stake in fertilizer producer Azoty Tarnow, four market sources close to the transaction told Reuters on Friday.

The price values the stake at 148 million zlotys ($54 million) and the entire company at 1.45 billion.

Tarnow shares pared some of their earlier losses and traded 2% down from Thursday's close at 37.99 zlotys, while PGNiG shares were up 0.3% to 3.78 zlotys.

PGNiG was not immediately available for comment.

The state-controlled gas monopoly bought its stake in Tarnow for 19.5 zlotys a share in 2008 when, together with Ciech, it stepped in to save Tarnow's privatization process.

At the time PGNiG considered consolidating the chemical industry in Poland, one of its biggest clients, but due to tough conditions in the fertilizer market it decided to abandon the plan and focus on entering the energy market.

"PGNiG took advantage of relatively good sentiment in the fertilizer market and the relatively high price of Tarnow," an analyst said on a condition of anonymity. "I would not be tying this move to the dividend decision."

PGNiG surprised the market on Thursday with its decision to pay all of its dividend in cash, moving away from an earlier plan to pay a part of the proposed 0.06 zloty dividend in kind.

For years PGNiG has paid the state's part of dividend in kind, transferring ownership of its extended pipeline system to the state.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.